The United Laboratories International Holdings ( (HK:3933) ) has shared an update.
The United Laboratories International Holdings Limited has announced that its subsidiary, Zhuhai United Laboratories Co., Ltd, Zhongshan Branch, received approval from the China National Medical Products Administration for its Polyvinyl Alcohol Eye Drops. This product, designed to treat and alleviate symptoms of dry eye syndrome, enhances the company’s ophthalmic product pipeline and strengthens its market position in the field of dry eye treatment.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, focusing on the pharmaceutical industry. It specializes in the development and production of various medical products, with a particular emphasis on ophthalmic treatments.
YTD Price Performance: 28.16%
Average Trading Volume: 13,212
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $3.62B
For a thorough assessment of 3933 stock, go to TipRanks’ Stock Analysis page.